Skip to content
healthcare.dev

GUAIFENESIN

NDC 62207-569, GUAIFENESIN, tablet, extended release, from Granules India Ltd.

Product NDC
62207-569
Status
Listed
Labeler
Granules India Ltd
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA213420
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62207-569 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN1200 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
62207-569-93622070569935 POUCH in 1 BOX (62207-569-93) / 2000 TABLET, EXTENDED RELEASE in 1 POUCH
62207-569-99622070569994200 TABLET, EXTENDED RELEASE in 1 BAG (62207-569-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62207-569 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62207-569 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62207-569. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.